Thursday, January 21st, 2021
DoD/HHS contract will enable onshore production of three vital medicines to treat critically ill patients, including those with COVID-19. CONTINUUS will build the first GMP-certified end-to-end manufacturing facility using its proprietary technology for the production of small-molecule medicines
Click here…